Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Misses on Revenue, Stock Down 3.42%

Adaptive Biotechnologies reported a wider-than-expected loss per share but did not provide revenue figures or guidance. The stock reacted negatively, dropping 3.42%, likely due to the lack of revenue information and forward guidance, which may raise concerns among investors about future performance.